National survey on the opinions of French specialists in assisted reproductive technologies about social issues impacting the future revision of the French Bioethics laws

Creux, H.; Diaz, Marie; Grynberg, Michaël; Papaxanthos-Roche, Aline; Chansel‐Debordeaux, Lucie; Jimenez, C.; Frantz, Sandrine; Chevalier, Nicolas; Takefman, Janet; Hocké, C.

doi:10.1016/j.jogoh.2020.101902

Cited by 6 publications

(3 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A 2022 study found that only 43% of egg donors in Kazakhstan were satisfied with the information they received on the accounting and outcomes of their donations (16). This is far lower than rates of upwards of 80% seen in the United Kingdom and Spain (29)(30)(31). Our analysis also supports calls for expanded genetic testing, given research showing high risks of chromosomal variations in Kazakh couples struggling with infertility (8).…”

Section: Discussionsupporting

confidence: 72%

Establishment of a Unified Register of Donor Sexual Gametes in the Republic of Kazakhstan

Chalova,

Lokshin,

Kiyan

et al. 2024

ama

View full text Add to dashboard Cite

Objective. The purpose of this narrative review paper was to review the state and development of the field of donor gametes in Kazakhstan, compare its legislative and technical capabilities with other countries and identify key steps towards the establishment of a unified register of donor gametes in the Republic. Materials and Methods. The narrative review paper conducted an analysis of scientific publications and legal documents to examine the implementation of Assisted Reproductive Technologies (ART), focusing on Donor Sexual Gametes (DSG), globally. It utilized medical publications from 2019 to 2023, legal acts, and recommendations from global health organizations to analyze eligibility criteria, legal regulations, and the social aspects of ART across different regions. Results. In Kazakhstan, ART is regulated by legislation, with DSG procedures governed by age limits, medical screening, and restrictions on the number of children born from donated gametes. Worldwide, practices vary, but there is growing interest in establishing a unified register of reproductive donor material to enhance transparency and accountability. However, legal gaps and ethical considerations must be addressed. Conclusion. The study identifies gaps in Kazakhstan’s legisla- tion compared to Western countries, emphasizing the necessity for enhanced legal rights for donors and recipients, including options for anonymity. Ethical concerns highlight the importance of confidentiality and data security in accessing the donor registry. Overall, implementing such a register promises to enhance transparency, safety, and accountability in reproductive medicine.

show abstract

Section: Discussionsupporting

confidence: 72%

Establishment of a Unified Register of Donor Sexual Gametes in the Republic of Kazakhstan

Chalova,

Lokshin,

Kiyan

et al. 2024

ama

View full text Add to dashboard Cite

show abstract

“… 192 193 194 On the other hand, feminists are against any kind of surrogacy. 63 195 196 Curiously, a recent meta-analysis showed that the majority of infertile women were not in favor of surrogacy. 197 198 A study in Romania revealed that women (general population) would rather adopt than resort to surrogacy.…”

Section: Ethical Issuesmentioning

confidence: 99%

Commercial Surrogacy: An Overview

Brandão

Garrido

2022

Rev Bras Ginecol Obstet

View full text Add to dashboard Cite

Objective Surrogacy is the process in which a woman carries and delivers a baby to other person or couple, known as intended parents. When carriers are paid for surrogacy, this is known as commercial surrogacy. The objective of the present work is to review the legal, ethical, social, and cultural aspects of commercial surrogacy, as well as the current panorama worldwide. Methods This is a review of the literature published in the 21st century on commercial surrogacy. Results A total of 248 articles were included as the core of the present review. The demand for surrogate treatments by women without uterus or with important uterine disorders, single men and same-sex male couples is constantly increasing worldwide. This reproductive treatment has important ethical dilemmas. In addition, legislation defers widely worldwide and is in constant change. Therefore, patients look more and more for treatments abroad, which can lead to important legal problems between countries with different laws. Commercial surrogacy is practiced in several countries, in most of which there is no specific legislation. Some countries have taken restrictive measures against this technique because of reports of exploitation of carriers. Conclusion Commercial surrogacy is a common practice, despite important ethical and legal dilemmas. As a consequence of diverse national legislations, patients frequently resort to international commercial surrogacy programs. As of today, there is no standard international legal context, and this practice remains largely unregulated.

show abstract

“…Desafortunadamente, la mayoría de las investigaciones que consideran estas implicaciones bioéticas se orienta a ensayos clínicos o epidemiológicos con seres humanos, haciendo énfasis en el derecho que tienen los participantes de ser informados sobre la manera como se emplearán las muestras o los procedimientos a los que fueron sometidos y la necesidad de contar con su consentimiento para el empleo de la información recabada en los estudios. El consentimiento informado es una pieza fundamental en las investigaciones en humanos, que prioriza la dignidad, la autonomía y el bienestar de las personas por sobre cualquier criterio que no reconozca estos aspectos (31,32).…”

Section: El Papel De La Bioética En La Investigación Biomédicaunclassified

Perspectiva bioética para México, España y Estados Unidos en los modelos in vivo de inducción de daño al ADN

Guerson

Márquez

Pascual-Mathey

2022

Rev. latinoam. bioet

View full text Add to dashboard Cite

En la actualidad, la investigación biomédica se ha centrado en el estudio de enfermedades como el cáncer, que causan un elevado índice de mortalidad. Existen diferentes modelos animales, empleados para generar diversos tipos de carcinogénesis; el daño directo al ADN es uno de los mecanismos más utilizados. Sin embargo, en la normatividad nacional e internacional vigente, no se señalan los aspectos bioéticos que se deben seguir para desarrollar un modelo experimental de daño al ADN. Además, no se realiza una correcta semejanza de la enfermedad. Debido a lo anterior, esta revisión analiza los avances en cuanto a normatividad que se han generado en diferentes países, comparando los estudios encontrados en Estados Unidos, México y España. La perspectiva a futuro es poder contar con guías de experimentación actualizadas, que permitan pautar las normas necesarias para el adecuado desarrollo de los modelos de investigación animal de daño al ADN y que cumplan con la regla de las 3R en la experimentación animal. Esta iniciativa se debe de realizar en conjunto entre la Organización Mundial de la Salud y los organismos especializados en manejo y cuidado de animales de laboratorio en los ámbitos nacional e internacional.

show abstract

National survey on the opinions of French specialists in assisted reproductive technologies about social issues impacting the future revision of the French Bioethics laws

Cited by 6 publications

References 23 publications

Establishment of a Unified Register of Donor Sexual Gametes in the Republic of Kazakhstan

Establishment of a Unified Register of Donor Sexual Gametes in the Republic of Kazakhstan

Commercial Surrogacy: An Overview

Perspectiva bioética para México, España y Estados Unidos en los modelos in vivo de inducción de daño al ADN

Contact Info

Product

Resources

About